PBE Expert Français

Biotechnology

Plasma fractionation, oncology and biosimilars in Montreal

From 2016 to 2021 in Montreal, PBE Expert delivered EPCMV biotechnology projects for GCBT, Bosch and PurLab: a plasma fractionation plant, oncology oral solid dosage forms and injectables with OEL 5 containment, and a cytotoxic biosimilar.

Bags of blood plasma awaiting processing

Project fact sheet

Client
GCBT, Bosch and PurLab
Location
Montreal, Quebec
Years
2016 à 2021
Engagement
EPCMV
Facility
Plasma fractionation, oncology (OEL 5), cytotoxic biosimilar

Engagement : EPCMV

  1. EEngineeringEngineering
  2. PProcurementProcurement
  3. CConstructionConstruction
  4. MManagementManagement
  5. VValidationValidation

The facilities

  • Plasma fractionation
  • Oncology oral solid dosage forms and injectables, with OEL 5 containment
  • Cytotoxic biosimilar

See also

Next project · Montreal, QuebecBSL-2 vaccinesFor a contract vaccine manufacturer (CMO) in Montreal, PBE Expert led the EPCMV delivery of a sterile BSL-2 facility, from design to inspection.

See alsoProjectsFormAction™

Let’s talk about your project.

A new site, an expansion, an inspection to prepare for: describe your project and one of our experts will get back to you.

Talk to an Expert